BR9709370A - Gene semelhante a tolóide de mamìfero e proteìna. - Google Patents

Gene semelhante a tolóide de mamìfero e proteìna.

Info

Publication number
BR9709370A
BR9709370A BR9709370-0A BR9709370A BR9709370A BR 9709370 A BR9709370 A BR 9709370A BR 9709370 A BR9709370 A BR 9709370A BR 9709370 A BR9709370 A BR 9709370A
Authority
BR
Brazil
Prior art keywords
protein
toloid
gene
mammalian
bmp
Prior art date
Application number
BR9709370-0A
Other languages
English (en)
Inventor
Daniel S Greenspan
Kazuhiro Takahara
Guy G Hoffman
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of BR9709370A publication Critical patent/BR9709370A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"GENE SEMELHANTE A TOLóIDE DE MAMìFERO E PROTEìNA". é apresentado um gene de mamífero codificado uma proteína semelhante a tolóide distinta de BMP-1/mTlD humano ou murino. O gene é semelhante em estrutura, aos elementos da família BMP-1 dos genes, porém mapeia para uma localização distinta e codifica uma proteína distinta. A proteína codificada pelo gene pode ser usada para classificar agentes putativos terapêuticos em um esforço em andamento para inibir a atividade da família BMP-1 dos genes, de modo a prevenir as cicatrizes, fibrose e semelhantes.
BR9709370-0A 1996-05-30 1997-05-30 Gene semelhante a tolóide de mamìfero e proteìna. BR9709370A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1868496P 1996-05-30 1996-05-30
PCT/US1997/009078 WO1997045528A2 (en) 1996-05-30 1997-05-30 Mammalian tolloid-like gene and protein

Publications (1)

Publication Number Publication Date
BR9709370A true BR9709370A (pt) 1999-10-05

Family

ID=21789256

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709370-0A BR9709370A (pt) 1996-05-30 1997-05-30 Gene semelhante a tolóide de mamìfero e proteìna.

Country Status (10)

Country Link
US (4) US5939321A (pt)
EP (1) EP0963203A4 (pt)
JP (1) JP2000511423A (pt)
KR (1) KR20000016143A (pt)
CN (1) CN1220608A (pt)
AU (1) AU3288497A (pt)
BR (1) BR9709370A (pt)
CA (1) CA2253818A1 (pt)
IL (1) IL126923A0 (pt)
WO (1) WO1997045528A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008017A (en) * 1997-01-02 1999-12-28 Smithkline Beecham Corporation Human cardiac/brain tolloid-like protein
US6037139A (en) * 1997-06-03 2000-03-14 Wisconsin Alumni Research Foundation System for assaying modulators of procollagen maturation
CN1154735C (zh) 1998-04-03 2004-06-23 威斯康星校友研究基金会 哺乳动物的特洛德样基因和蛋白质
AU5274000A (en) 1999-06-04 2000-12-28 Sunrise Technologies International, Inc. Prevention of regression in refractive keratoplasty
US20030077279A1 (en) * 2001-10-24 2003-04-24 Cedars-Sinai Medical Center Methods for treating vascular disease by inhibiting toll-like receptor-4
AU2002366331A1 (en) * 2001-12-17 2003-06-30 Cedars-Sinai Medical Center Treating vascular disease by inhibiting myeloid differentiation factor 88
EP1932907A1 (en) * 2006-12-12 2008-06-18 Novartis AG Crystal structure of the catalytic domain of tolloid-like protease 1 and uses thereof
US9512196B2 (en) 2008-09-22 2016-12-06 Cedars-Sinai Medical Center Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling
WO2010033294A1 (en) 2008-09-22 2010-03-25 Cedars-Sinai Medical Center Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
SG11201605539SA (en) 2014-01-10 2016-08-30 Glaxosmithkline Ip No 2 Ltd Hydroxy formamide derivatives and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008017A (en) * 1997-01-02 1999-12-28 Smithkline Beecham Corporation Human cardiac/brain tolloid-like protein

Also Published As

Publication number Publication date
IL126923A0 (en) 1999-09-22
EP0963203A4 (en) 2001-04-11
WO1997045528A2 (en) 1997-12-04
AU3288497A (en) 1998-01-05
US20020048565A1 (en) 2002-04-25
US5981717A (en) 1999-11-09
EP0963203A2 (en) 1999-12-15
KR20000016143A (ko) 2000-03-25
CN1220608A (zh) 1999-06-23
US6297011B1 (en) 2001-10-02
US5939321A (en) 1999-08-17
CA2253818A1 (en) 1997-12-04
JP2000511423A (ja) 2000-09-05
WO1997045528A3 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
ATE251140T1 (de) N-(2 oxoacetyl oder sulphonyl)- pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
DE3768546D1 (de) Mittel zur verabreichung von hyaluronsaeure an saeuger.
BR9709370A (pt) Gene semelhante a tolóide de mamìfero e proteìna.
BR9910251A (pt) Estimulação hematopoiética
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
DE69023574D1 (de) Amphotere Zusammensetzungen und Polymerformen von alpha-Hydroxy-Säuren, und ihre therapeutische Anwendung.
DE69434538D1 (de) Vaskularer endothelialer wachstumsfaktor 2
BR9916974A (pt) Tablete detergente
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
BR9907788A (pt) Agentes antiinflamatórios seletivos paraglicocorticóides
NO20002440L (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
AU548324B2 (en) Biotin antagonist composition for use on skin and hair
SE9800806L (sv) Användning av kollagenas
ATE215540T1 (de) Benzofuran-carboxamide und -sulfonamide
ATE273026T1 (de) Komplexe von hyaluronic saure/carnitinen und pharmazeutische und kosmetische zusammensetzungen
KR940018087A (ko) 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
BR0114407A (pt) Mutantes de quimiocina no tratamento de esclerose múltipla
PL375087A1 (en) Low molecular weight oversulfated polysaccharide
PT1058544E (pt) Inibicao da actividade do tnf
PT986386E (pt) Uso de derivados heterociclicos aromaticos com azoto no tratamento topico de doencas dos tecidos epiteliais
WO1999051730A3 (en) Mammalian gene encoding tolloid-like protein
BR0012856A (pt) Aspergillus sojae recombinante, métodos para introduzir uma sequência de ácido nucleico em aspergillus sojae, para selecionar aspergillus sojae transformado ou transfectado, para produzir aspergillus sojae recombinante, aspergillus sojae mutante ou recombinante, fungo recombinante processos de expressão de uma sequência de ácido, nucleico introduzida, para a expressão de uma proteìna ou polipeptìdeo, para a produção de uma proteìna ou polipeptìdeo, e, para produzir uma fitase ou uma proteìna tendo atividade fitase
DE69835210D1 (de) Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]